Edema: all 840 studies
Page 7 of 9. Open to participants first (92), then studies with results posted, then the rest; newest registration first within each.
- Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 StudyWithdrawnNCT02511067Phase 2
- Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular EdemaTerminatedNCT02485249Phase 1/2
- Oedematous Lower Limb Subcutaneous Drainage in Palliative CareTerminatedNCT02473744Not applicable
- To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular EdemaStatus unknownNCT02462304Phase 4
- Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular OedemaCompletedNCT02457884Not applicable
- Topical Nepafenac as Supplement for Diabetic Macular EdemaCompletedNCT02443012Phase 4
- Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular EdemaCompletedNCT02441907Phase 4
- Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic EdemaCompletedNCT02427880Phase 4
- Special Drug Use Investigation of EYLEA for Diabetic Macular EdemaCompletedNCT02425501
- 577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular EdemaCompletedNCT02406157Not applicable
- Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular EdemaStatus unknownNCT02399657Phase 4
- Variable Interval Versus Set Interval Aflibercept for DMECompletedNCT02392364Phase 4
- Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBICompletedNCT02368366Not applicable
- A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema PatientsCompletedNCT02359526Phase 4
- Impact of Rational Control of Fluid Balance in the Intensive Care UnitCompletedNCT02345681Phase 3
- ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial DystrophyCompletedNCT02332109
- Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular EdemaCompletedNCT02329132
- Optimization of Onpulse Technology for Patients With Post Surgical or Vascular OedemaCompletedNCT02316210Early Phase 1
- A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular DegenerationCompletedNCT02314299Phase 1/2
- Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular EdemaCompletedNCT02310295Not applicable
- Sub-threshold Photocoagulation of Diabetic Macular OedemaWithdrawnNCT02309476Not applicable
- Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity StudyCompletedNCT02308644Phase 3
- A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)CompletedNCT02302079Phase 2
- Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone AcetonideCompletedNCT02294656Phase 1
- A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular EdemaWithdrawnNCT02281292Phase 1
- Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaWithdrawnNCT02258009Phase 4
- Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular EdemaWithdrawnNCT02229175Phase 2/3
- Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular EdemaStatus unknownNCT02227745
- Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone AcetonideCompletedNCT02221453Phase 2
- Contrast Sensitivity and Diabetic Macular EdemaCompletedNCT02217306
- A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DMECompletedNCT02193113Phase 1
- Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein OcclusionStatus unknownNCT02169648Not applicable
- Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula EdemaCompletedNCT02131350Phase 4
- Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF DosingWithdrawnNCT02127684Phase 2
- Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.CompletedNCT02121197
- Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular EdemaCompletedNCT02096874Phase 4
- Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular EdemaCompletedNCT02088229
- Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After PhacoemulsificationCompletedNCT02084576Phase 4
- Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak RepublicStatus unknownNCT02063321
- Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular EdemaStatus unknownNCT02059772Phase 4
- Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular EdemaWithdrawnNCT02055911Phase 4
- The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular EdemaCompletedNCT02050828Phase 2
- Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular EdemaCompletedNCT02002403Phase 2
- The Intraocular Pressure Measured by Different Tonometers in Corneal EdemaCompletedNCT01998568
- Study of Stroke Related Edema TreatmentsWithdrawnNCT01954290Phase 2
- Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)CompletedNCT01947881
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGFTerminatedNCT01946399Not applicable
- Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass SyndromeCompletedNCT01945892
- Macular Edema Nepafenac vs. Difluprednate Uveitis TrialTerminatedNCT01939691Phase 4
- Does NMES Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?Status unknownNCT01936155Not applicable
- Identifying Patients With Unrecognized Treatable Diabetic Macular EdemaStatus unknownNCT01934920
- Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular EdemaStatus unknownNCT01928654Not applicable
- Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot StudyCompletedNCT01899963
- Myocardial Oedema in ST Segment Elevation Myocardial Infarction MyocardialCompletedNCT01897350
- Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal EdemaCompletedNCT01890252Not applicable
- Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)CompletedNCT01887379Phase 1
- Acute Congestive Heart FailureStatus unknownNCT01885403Not applicable
- Pilot Study of OCT Versus Fluorescein Angiography in DMECompletedNCT01876914
- TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular EdemaCompletedNCT01870440Phase 4
- NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein OcclusionsCompletedNCT01870427Phase 4
- The Effect of Neuromuscular Stimulation on Post-Transplant Leg EdemaCompletedNCT01860820Not applicable
- Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care PatientsStatus unknownNCT01857674
- Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic CancerStatus unknownNCT01849224Phase 3
- Ranibizumab For Persistent Diabetic Macular Edema After BevacizumabStatus unknownNCT01845844Phase 1/2
- Bioimpedance Spectroscopy for the Differential Diagnosis of HyponatremiaCompletedNCT01838759
- Reduction of Foveal Sensitivity in Eyes With Diabetic Macular EdemaCompletedNCT01824862
- Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair VisionTerminatedNCT01795209Phase 4
- Glyburide Advantage in Malignant Edema and Stroke - Remedy PharmaceuticalsCompletedNCT01794182Phase 2
- Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal PhotographyStatus unknownNCT01790945
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01787669Phase 2
- PRevention of Macular EDema After Cataract SurgeryCompletedNCT01774474Phase 3
- Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF TherapyCompletedNCT01771081
- Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)Status unknownNCT01763853Phase 4
- Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs PlaceboSuspendedNCT01734824Phase 4
- Topcon Endpoint ManagementCompletedNCT01732614Not applicable
- Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular EdemaCompletedNCT01702441Phase 1/2
- Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular EdemaCompletedNCT01698788Not applicable
- Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular EdemaCompletedNCT01698749Not applicable
- Hemodynamic Changes in Altitude AdaptationStatus unknownNCT01698619
- Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic RetinopathyCompletedNCT01694212Not applicable
- Study of Idiopathic EdemaCompletedNCT01681927
- DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01662518Phase 1/2
- Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic HydropsWithdrawnNCT01661777Not applicable
- Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac EdemaCompletedNCT01651156Phase 3
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)Status unknownNCT01635790Phase 2/3
- Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow LesionsCompletedNCT01621893
- Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart FailureCompletedNCT01618448Phase 3
- Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective DiuresisWithdrawnNCT01617798Not applicable
- Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain InjuryWithdrawnNCT01605357Phase 1/2
- Effects of Hyperbaric Oxygen Therapy on Surgical Wound HealingStatus unknownNCT01605110Not applicable
- Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaCompletedNCT01572350Phase 3
- Sleep and Cerebral Responses to High AltitudeStatus unknownNCT01565603
- The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular OedemaCompletedNCT01564108Phase 2
- Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular EdemaStatus unknownNCT01523314Phase 2/3
- The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)CompletedNCT01518907Phase 1
- Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)CompletedNCT01512966Phase 3
- Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)CompletedNCT01512901Phase 2/3
- Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular EdemaStatus unknownNCT01487629Phase 2
- Safety Study of ALG- 1001 to Treat Diabetic Macular EdemaWithdrawnNCT01482871Phase 1/2
- Autologous Plasmin and Fibrinolytic System in Diabetic RetinopathyStatus unknownNCT01478516Not applicable